Browse by People

Collapse authors list.
Steegmann, JL, Baccarani, M, Breccia, M, Casado, LF, Garcia-Gutierrez, V, Hochhaus, A, Kim, D-W, Kim, TD, Khoury, HJ, Le Coutre, P et al (show 8 more authors) , Mayer, J, Milojkovic, D, Porkka, K, Rea, D, Rosti, G, Saussele, S, Hehlmann, R and Clark, RE ORCID: 0000-0002-1261-3299 (2016) European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia. LEUKEMIA, 30 (8). pp. 1648-1671.

Collapse authors list.
Horne, GA, Stobo, J, Kelly, C, Mukhopadhyay, A, Latif, AL, Dixon-Hughes, J, McMahon, L, Cony-Makhoul, P, Byrne, J, Smith, G et al (show 13 more authors) , Koschmieder, S, BrUemmendorf, TH, Schafhausen, P, Gallipoli, P, Thomson, F, Cong, W, Clark, RE ORCID: 0000-0002-1261-3299, Milojkovic, D, Helgason, GV, Foroni, L, Nicolini, FE, Holyoake, TL and Copland, M (2020) A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. LEUKEMIA, 34 (7). pp. 1775-1786.